Using therapeutic cloning to fight human disease: A conundrum or reality?

Stem Cells

Volumn 24, Issue 7, 2006, Pages 1628-1637

  Hall, Vanessa J ^a,c   Stojkovic, Petra ^b   Stojkovic, Miodrag ^b  

^a LUND UNIVERSITY   (Sweden)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Clinical stem cell transplantation; Cloning; Human embryonic stem cells; Reprogramming

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CELL CLONING; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; CELL NUCLEUS TRANSPLANTATION; CELL TRANSPLANTATION; CELL TYPE; EMBRYONIC STEM CELL; EPIGENETICS; EUROPE; GENE EXPRESSION; GENE MUTATION; GRAFT REJECTION; HETEROPLASMY; HUMAN; LAW; MEDICAL ETHICS; MEDICAL RESEARCH; MITOCHONDRION; MORALITY; NONHUMAN; OOCYTE; PATIENT SAFETY; PRIMATE; REVIEW; SOCIAL ASPECT; SOMATIC CELL; ANIMAL; BIOLOGICAL MODEL; CLONING; ETHICS; GENETIC EPIGENESIS; GENETICS; LEGAL ASPECT; METABOLISM; MITOCHONDRIAL GENE; MUTATION; OOCYTE DONATION; PSYCHOLOGICAL ASPECT; STEM CELL TRANSPLANTATION; UTILIZATION REVIEW;

MITOCHONDRIAL DNA;

ANIMALS; CLONING, ORGANISM; DNA, MITOCHONDRIAL; EPIGENESIS, GENETIC; GENES, MITOCHONDRIAL; GRAFT REJECTION; HUMANS; MODELS, BIOLOGICAL; MUTATION; OOCYTE DONATION; STEM CELL TRANSPLANTATION;

EID: 33749048146     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0592     Document Type: Review

References (99)

1. Kind A, Colman A. Therapeutic cloning: Needs and prospects. Semin Cell Dev Biol 1999;10:279-286.
2. Lanza RP, Cibelli JB, West MD. Human therapeutic cloning. Nat Med 1999;5:975-977.
3. Trounson A. Nuclear transfer in human medicine and animal breeding. Reprod Fertil Dev 2001;13:31-39.
4. Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A. Embryonic stem cells: A promising tool for cell replacement therapy. J Cell Mol Med 2004;8:465-473.
5. Hoffman LM, Carpenter MK. Characterization and culture of human embryonic stem cells. Nat Biotechnol 2005;23:699-708.
6. Vats A, Tolley NS, Bishop AE et al. Embryonic stem cells and tissue engineering: Delivering stem cells to the clinic. J R Soc Med 2005;98:346-350.
7. Munsie MJ, Michalska AE, O'Brien CM et al. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol 2000;10:989-992.
8. Kawase E, Yamazaki Y, Yagi T et al. Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocysts. Genesis 2000;28:156-163.
9. Wakayama T, Tabar V, Rodriguez I et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001;292:740-743.
10. Rideout WM 3rd, Hochedlinger K, Kyba M et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 2002;109:17-27.
11. Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003;21:1200-1207.
12. Down JD, White-Scharf ME. Reprogramming immune responses: Enabling cellular therapies and regenerative medicine. STEM CELLS 2003;21:21-32.
13. Strom TB, Field LJ, Ruediger M. Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine. Curr Opin Immunol 2002;14:601-605.
14. Takagi Y, Takahashi J, Saiki H et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 2005;115:102-109.
15. Faulkner J, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl Immunol 2005;15:131-142.
16. Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705.
17. Kimura H, Yoshikawa M, Matsuda R et al. Transplantation of embryonic stem cell-derived neural stem cells for spinal cord injury in adult mice. Neurol Res 2005;27:812-819.
18. Menard C, Hagege AA, Agbulut O et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study. Lancet 2005;366:1005-1012.
19. Stojkovic M, Stojkovic P, Leary C et al. Derivation of a human blastocyst after heterologous nuclear transfer to donated oocytes. Reprod Biomed Online 2005;11:226-231.
20. Lavoir M-C, Weier J, Conaghan J et al. Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reprod Biomed Online 2005;11:740-744.
21. Simerly C, Navara C, Hyun SH et al. Embryogenesis and blastocyst development after somatic cell nuclear transfer in nonhuman primates: Overcoming defects caused by meiotic spindle extraction. Dev Biol 2004;276:237-252.
22. Simerly C, Dominko T, Navara C et al. Molecular correlates of primate nuclear transfer failures. Science 2003;300:297.
23. Meng L, Ely JJ, Stouffer RL et al. Rhesus monkeys produced by nuclear transfer. Biol Reprod 1997;57:454-459.
24. Ludwig TE, Levenstein ME, Jones JM et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006;24:185-187.
25. Takagi Y, Nishimura M, Morizane A et al. Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain. J Neurosurg 2005;103:304-310.
26. Ruschenschmidt C, Koch PG, Brustle O et al. Functional properties of ES cell-derived neurons engrafted into the hippocampus of adult normal and chronically epileptic rats. Epilepsia 2005;46(suppl 5):174-183.
27. Fujikawa T, Oh SH, Pi L et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 2005;166:1781-1791.
28. Mombaerts P. Therapeutic cloning in the mouse. Proc Natl Acad Sci U S A 2003;100(suppl 1):11924-11925.
29. Blyth E. Subsidized IVF. The development of 'egg sharing' in the United Kingdom. Hum Reprod 2002;17:3254-3259.
30. Heng BC. Egg-sharing in return for subsidized fertility treatment - an ethically justifiable and practical solution to overcome the shortage of donor oocytes for therapeutic cloning. Med Hypotheses 2005;65:999-1000.
31. Couzin J. Stem cells. Another route to oocytes? Science 2005;309:1983.
32. Hubner K, Fuhrmann G, Christenson LK et al. Derivation of oocytes from mouse embryonic stem cells. Science 2003;300:1251-1256.
33. Kehler J, Hubner K, Garrett S et al. Generating oocytes and sperm from embryonic stem cells. Semin Reprod Med 2005;23:222-233.
34. Daar AS, Bhatt A, Court E et al. Stem cell research and transplantation: Science leading ethics. Transplant Proc 2004;36:2504-2506.
35. Schenker JG. Assisted reproductive practice: Religious perspectives. Reprod Biomed Online 2005;10:310-319.
36. Brun RB. Cloning humans? Current science, current views, and a perspective from Christianity. Differentiation 2002;69:184-187.
37. Charter of Fundamental Rights of the European Union. Available at http://www.europarl.europa.eu/comparl/libe/elsg/charter/default_en.htm. Accessed April 2, 2006.
38. Wertz DC. Embryo and stem cell research in the United States: History and politics. Gene Ther 2002;9:674-678.
39. Childress JF. Human stem cell research: Some controversies in bioethics and public policy. Blood Cells Mol Dis 2004;32:100-105.
40. Check E. Stem-cell research: The rocky road to success. Nature 2005;437:185-186.
41. Meissner A, Jaenisch R. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 2006;439:212-215.
42. St John JC, Schatten G. Paternal mitochondrial DNA transmission during nonhuman primate nuclear transfer. Genetics 2004;167:897-905.
43. Steinborn R, Schinogl P, Zakhartchenko V et al. Mitochondrial DNA heteroplasmy in cloned cattle produced by fetal and adult cell cloning. Nat Genet 2000;25:255-257.
44. Hiendleder S, Zakhartchenko V, Wenigerkind H et al. Heteroplasmy in bovine fetuses produced by intra- and inter-subspecific somatic cell nuclear transfer: Neutral segregation of nuclear donor mitochondrial DNA in various tissues and evidence for recipient cow mitochondria in fetal blood. Biol Reprod 2003;68:159-166.
45. Takeda K, Takahashi S, Onishi A et al. Dominant distribution of mitochondrial DNA from recipient oocytes in bovine embryos and offspring after nuclear transfer. J Reprod Fertil 1999;116:253-259.
46. Steinborn R, Zakhartchenko V, Wolf E et al. Non-balanced mix of mitochondrial DNA in cloned cattle produced by cytoplast-blastomere fusion. FEBS Lett 1998;426:357-361.
47. Hiendleder S, Schmutz SM, Erhardt G et al. Transmitochondrial differences and varying levels of heteroplasmy in nuclear transfer cloned cattle. Mol Reprod Dev 1999;54:24-31.
48. Evans MJ, Gurer C, Loike JD et al. Mitochondrial DNA genotypes in nuclear transfer-derived cloned sheep. Nat Genet 1999;23:90-93.
49. Brenner CA, Kubisch HM, Pierce KE. Role of the mitochondrial genome in assisted reproductive technologies and embryonic stem cell-based therapeutic cloning. Reprod Fertil Dev 2004;16:743-751.
50. Lanza RP, Chung HY, Yoo JJ et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 2002;20:689-696.
51. Raisky O, Gomez L, Chalabreysse L et al. Mitochondrial permeability transition in cardiomyocyte apoptosis during acute graft rejection. Am J Transplant 2004;4:1071-1078.
52. Kristal BS, Stavrovskaya IG, Narayanan MV et al. The mitochondrial permeability transition as a target for neuroprotection. J Bioenerg Biomembr 2004;36:309-312.
53. Vats A, Bielby RC, Tolley NS et al. Stem cells. Lancet. 2005;366:592-602.
54. Dabhi VM, Lindahl KF. MtDNA-encoded histocompatibility antigens. Methods Enzymol 1995;260:466-485.
55. Fischer Lindahl K, Hermel E, Loveland BE et al. Maternally transmitted antigen of mice: A model transplantation antigen. Annu Rev Immunol 1991;9:351-372.
56. Zavazava N, Kabelitz D. Alloreactivity and apoptosis in graft rejection and transplantation tolerance. J Leukoc Biol 2000;68:167-174.
57. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-176.
58. Kahan BD. Cyclosporine: A revolution in transplantation. Transplant Proc 1999;31(1-2A):14S-15S.
59. Streilein JW. Peripheral tolerance induction: Lessons from immune privileged sites and tissues. Transplant Proc 1996;28:2066-2070.
60. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6:389-402.
61. Dimauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med 2005;37:222-232.
62. Chinnery PF, Thorburn DR, Samuels DC et al. The inheritance of mitochondrial DNA heteroplasmy: Random drift, selection or both? Trends Genet 2000;16:500-505.
63. Morgan HD, Santos F, Green K et al. Epigenetic reprogramming in mammals. Hum Mol Genet 2005;14(spec 1):R47-R58.
64. Humpherys D, Eggan K, Akutsu H et al. Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad Sci U S A 2002;99:12889-12894.
65. Jouneau A, Renard JP. Reprogramming in nuclear transfer. Curr Opin Genet Dev 2003;13:486-491.
66. Niemann H, Wrenzycki C, Lucas-Hahn A et al. Gene expression patterns in bovine in vitro-produced and nuclear transfer-derived embryos and their implications for early development. Cloning Stem Cells 2002;4:29-38.
67. Wrenzycki C, Herrmann D, Lucas-Hahn A et al. Gene expression patterns in in vitro-produced and somatic nuclear transfer-derived preimplantation bovine embryos: Relationship to the large offspring syndrome? Anim Reprod Sci 2004;82-83:593-603.
68. Hall VJ, Ruddock NT, French AJ. Expression profiling of genes crucial for placental and preimplantation development in bovine in vivo, in vitro, and nuclear transfer blastocysts. Mol Reprod Dev 2005;72:16-24.
69. Dean W, Santos F, Stojkovic M et al. Conservation of methylation reprogramming in mammalian development: Aberrant reprogramming in cloned embryos. Proc Natl Acad Sci U S A 2001;98:13734-13738.
70. Humpherys D, Eggan K, Akutsu H et al. Epigenetic instability in ES cells and cloned mice. Science 2001;293:95-97.
71. Santos F, Zakhartchenko V, Stojkovic M et al. Epigenetic marking correlates with developmental potential in cloned bovine preimplantation embryos. Curr Biol 2003;13:1116-1121.
72. Xue F, Tian XC, Du F et al. Aberrant patterns of X chromosome inactivation in bovine clones. Nat Genet 2002;31:216-220.
73. Eggan K, Akutsu H, Hochedlinger K, Rideout W 3rd et al. X-chromosome inactivation in cloned mouse embryos. Science 2000;290:1578-1581.
74. Mann MR, Chung YG, Nolen LD et al. Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol Reprod 2003;69:902-914.
75. Skottman H, Mikkola M, Lundin K et al. Gene expression signatures of seven individual human embryonic stem cell lines. STEM CELLS 2005;23:1343-1356.
76. Yang X, Tian XC. Cloning adult animals-what is the genetic age of the clones? Cloning 2000;2:123-128.
77. Shiels PG, Kind AJ, Campbell KH et al. Analysis of telomere length in Dolly, a sheep derived by nuclear transfer. Cloning 1999;1:119-125.
78. Jiang L, Carter DB, Xu J et al. Telomere lengths in cloned transgenic pigs. Biol Reprod 2004;70:1589-1593.
79. Jeon HY, Hyun SH, Lee GS et al. The analysis of telomere length and telomerase activity in cloned pigs and cows. Mol Reprod Dev 2005;71:315-320.
80. Miura T, Mattson MP, Rao MS. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 2004;3:333-343.
81. Young HE, Duplaa C, Katz R et al. Adult-derived stem cells and their potential for use in tissue repair and molecular medicine. J Cell Mol Med 2005;9:753-769.
82. Rice CM, Scolding NJ. Adult stem cells-reprogramming neurological repair? Lancet 2004;364:193-199.
83. Rubio D, Garcia-Castro J, Martin MC et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-3039.
84. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004;8:301-316.
85. Hassan HT, El-Sheemy M. Adult bone-marrow stem cells and their potential in medicine. J R Soc Med 2004;97:465-471.
86. Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 2002;99:9864-9869.
87. Westphal CH, Leder P. Transposon-generated 'knock-out' and 'knockin' gene-targeting constructs for use in mice. Curr Biol 1997;7:530-533.
88. Martinez OM, Krams SM. Involvement of Fas-Fas ligand interactions in graft rejection. Int Rev Immunol 1999;18:527-546.
89. Guillonneau C, Aubry V, Renaudin K et al. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation 2005;80:255-263.
90. Taylor CJ, Bolton EM, Pocock S et al. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-2025.
91. Cowan CA, Atienza J, Melton DA et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005;309:1369-1373.
92. Ambrosi DJ, Rasmussen TP. Reprogramming mediated by stem cell fusion. J Cell Mol Med 2005;9:320-330.
93. Ringertz N, Savage RE. Cell Hybrids. New York: Academic Press, 1976.
94. Weimann JM, Johansson CB, Trejo A et al. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 2003;5:959-966.
95. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422:897-901.
96. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-904.
97. Kiessling AA. Eggs alone. Nature. 2005;434:145.
98. Vrana KE, Hipp JD, Goss AM et al. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci U S A 2003;100(suppl 1):11911-11916.
99. Kotecki M, Reddy PS, Cochran BH. Isolation and characterization of a near-haploid human cell line. Exp Cell Res 1999;252:273-280.